Phosphorylation state and protein levels measured in BRAF(V600E/D) melanoma cell lines monitored by imaging - Dataset (ID:20219)
Download: Excel (XLSX), Comma-separated (CSV)
Small Molecule | Cell Line | 2nd Drug | Drug Concentration | Conc Unit | Time Point | Time Point Unit | Image | Measured Protein (Alexa Fluor 488) | Measured Protein Value (488) | Measured Protein (Alexa Fluor 568) | Measured Protein Value (568) | Measured Protein (Alexa Fluor 647) | Measured Protein Value (647) | Replicate | Plate Name | Plate Well |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0000 | uM | 24 | hr | p27 Kip1 | 351.99 | p-Rb(S807/S811) | 215.31 | p-ERK(T202/Y204) | 217.61 | 2 | LOXIMVI-signal1 | G11 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.0512 | uM | 24 | hr | p27 Kip1 | 511.00 | p-Rb(S807/S811) | 125.23 | p-ERK(T202/Y204) | 254.95 | 2 | Colo858-signal1 | G7 | |
JNK-IN-8 | WM-115 | 0.1280 | uM | 24 | hr | p27 Kip1 | 235.79 | p-Rb(S807/S811) | 81.08 | p-ERK(T202/Y204) | 651.65 | 2 | WM115-signal1 | E6 | ||
JNK-IN-8 | WM-115 | 0.0082 | uM | 24 | hr | p27 Kip1 | 226.04 | p-Rb(S807/S811) | 77.90 | p-ERK(T202/Y204) | 670.95 | 2 | WM115-signal1 | E9 | ||
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0033 | uM | 24 | hr | p27 Kip1 | 303.58 | p-Rb(S807/S811) | 202.43 | p-ERK(T202/Y204) | 184.11 | 2 | LOXIMVI-signal1 | G10 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0082 | uM | 24 | hr | p27 Kip1 | 310.13 | p-Rb(S807/S811) | 197.48 | p-ERK(T202/Y204) | 166.06 | 1 | LOXIMVI-signal1 | F9 | |
JNK-IN-8 | WM-115 | 2.0000 | uM | 24 | hr | p27 Kip1 | 250.02 | p-Rb(S807/S811) | 88.53 | p-ERK(T202/Y204) | 714.03 | 2 | WM115-signal1 | E3 | ||
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0205 | uM | 24 | hr | p27 Kip1 | 304.49 | p-Rb(S807/S811) | 193.11 | p-ERK(T202/Y204) | 131.86 | 1 | LOXIMVI-signal1 | F8 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0512 | uM | 24 | hr | p27 Kip1 | 338.89 | p-Rb(S807/S811) | 176.50 | p-ERK(T202/Y204) | 86.35 | 1 | LOXIMVI-signal1 | F7 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.1280 | uM | 24 | hr | p27 Kip1 | 743.36 | p-Rb(S807/S811) | 68.92 | p-ERK(T202/Y204) | 51.05 | 2 | Colo858-signal1 | G6 | |
JNK-IN-8 | WM-115 | 0.8000 | uM | 24 | hr | p27 Kip1 | 235.37 | p-Rb(S807/S811) | 88.77 | p-ERK(T202/Y204) | 657.24 | 2 | WM115-signal1 | E4 | ||
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.1280 | uM | 24 | hr | p27 Kip1 | 356.71 | p-Rb(S807/S811) | 166.33 | p-ERK(T202/Y204) | 71.63 | 1 | LOXIMVI-signal1 | F6 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.3200 | uM | 24 | hr | p27 Kip1 | 441.68 | p-Rb(S807/S811) | 125.56 | p-ERK(T202/Y204) | 43.30 | 1 | LOXIMVI-signal1 | F5 | |
JNK-IN-8 | COLO 858 | 0.0512 | uM | 24 | hr | p27 Kip1 | 430.28 | p-Rb(S807/S811) | 171.77 | p-ERK(T202/Y204) | 673.40 | 1 | Colo858-signal1 | D7 | ||
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.8000 | uM | 24 | hr | p27 Kip1 | 546.66 | p-Rb(S807/S811) | 87.40 | p-ERK(T202/Y204) | 40.47 | 1 | LOXIMVI-signal1 | F4 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 2.0000 | uM | 24 | hr | p27 Kip1 | 560.57 | p-Rb(S807/S811) | 82.73 | p-ERK(T202/Y204) | 44.60 | 1 | LOXIMVI-signal1 | F3 | |
Vemurafenib | COLO 858 | JNK-IN-8 | 0.3200 | uM | 24 | hr | p27 Kip1 | 983.23 | p-Rb(S807/S811) | 56.72 | p-ERK(T202/Y204) | 28.24 | 2 | Colo858-signal1 | G5 | |
Vemurafenib | COLO 858 | 2.0000 | uM | 24 | hr | p27 Kip1 | 1027.10 | p-Rb(S807/S811) | 46.02 | p-ERK(T202/Y204) | 14.33 | 2 | Colo858-signal1 | C3 | ||
JNK-IN-8 | WM-115 | 0.3200 | uM | 24 | hr | p27 Kip1 | 232.47 | p-Rb(S807/S811) | 84.23 | p-ERK(T202/Y204) | 633.23 | 2 | WM115-signal1 | E5 | ||
Vemurafenib | WM-115 | JNK-IN-8 | 0.0033 | uM | 24 | hr | p27 Kip1 | 224.00 | p-Rb(S807/S811) | 72.74 | p-ERK(T202/Y204) | 584.05 | 1 | WM115-signal1 | F10 | |
Vemurafenib | WM-115 | JNK-IN-8 | 0.0512 | uM | 24 | hr | p27 Kip1 | 235.54 | p-Rb(S807/S811) | 72.02 | p-ERK(T202/Y204) | 366.04 | 2 | WM115-signal1 | G7 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 5.0000 | uM | 24 | hr | p27 Kip1 | 598.80 | p-Rb(S807/S811) | 103.77 | p-ERK(T202/Y204) | 63.79 | 1 | LOXIMVI-signal1 | F2 | |
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0000 | uM | 24 | hr | p27 Kip1 | 362.35 | p-Rb(S807/S811) | 212.69 | p-ERK(T202/Y204) | 226.97 | 1 | LOXIMVI-signal1 | F11 | |
JNK-IN-8 | WM-115 | 0.0205 | uM | 24 | hr | p27 Kip1 | 235.89 | p-Rb(S807/S811) | 78.16 | p-ERK(T202/Y204) | 655.44 | 1 | WM115-signal1 | D8 | ||
Vemurafenib | LOXIMVI | JNK-IN-8 | 0.0033 | uM | 24 | hr | p27 Kip1 | 307.03 | p-Rb(S807/S811) | 198.87 | p-ERK(T202/Y204) | 175.67 | 1 | LOXIMVI-signal1 | F10 |